Skip to content

A retrospective study to assess the effectiveness and safety of lactulose retention enema in the treatment of cirrhotic patients with grade 3 or 4.

A retrospective, open-label, uncontrolled cohort study to assess the effectiveness and safety of lactulose retention enema in the treatment of cirrhotic patients with grade 3 or 4 (West Haven Criteria) hepatic encephalopathy (HE) [The RETRO Study] - The Retro study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2016/09/007260
Enrollment
50
Registered
2016-09-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- cirrhotic patients with grade 3 or 4 (West Haven Criteria) hepatic encephalopathy (HE)

Interventions

Sponsors

Abbott India Linited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients aged between 18 and 65 years of either gender 2 Patients admitted to the hospital with liver cirrhosis and grade 3 or grade 4 (West Haven Criteria) HE 3 Patients treated with lactulose retention enema within 48 hours of onset of grade 3 or 4 (West Haven Criteria) HE

Exclusion criteria

Exclusion criteria: 1. Patients treated with agents other than lactulose retention enema for grade 3 or 4 (West Haven Criteria) HE. 2 Patients who had significant concomitant diseases that could impair or contribute to the impairment of consciousness 3 Patients who had a major neuropsychiatric illness 4 Patients who had a contraindication to lactulose, including Hypersensitivity to the active substance or to any of the ingredients Galactosaemia Gastrointestinal obstruction digestive perforation or risk of digestive perforation

Design outcomes

Primary

MeasureTime frame
Complete reversal of deep-grade (Grade 3 and 4 West-Haven Criteria) HE after administration of lactulose retention enemaTimepoint: at 48 hours

Secondary

MeasureTime frame
1) Grade shift at 24 and 48 hours â?? before and after administration of lactulose retention enema 2) Time to complete reversal of deep-grade (Grade 3 and 4 West-Haven Criteria) HE after administration of lactulose retention enema 3) Mortality after administration of lactulose retention enemaTimepoint: 1) HE grade shift from baseline to 24 and 48 hours post treatment 2) Time to complete reversal of deep-grade (Grade 3 and 4 West Haven Criteria) HE after administration of lactulose retention enema 3) Mortality in patients treated with lactulose retention enema;1) Reduction in blood ammonia level, including time taken for the same, after administration of lactulose retention enema 2) Duration of hospital stayTimepoint: 1) Percentage reduction in blood ammonia level, including time taken for the same after treatment with lactulose retention enema 2) Duration of hospital stay in patients treated with lactulose retention enema

Countries

India

Contacts

Public ContactDr Kaushal Madan

Medanta Medicity

k_madan_2000@yahoo.com9958787720

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026